Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ceriptan is an oral dietary supplement developed by SPEY and manufactured by Aconitum. It is formulated as a capsule containing a combination of 5-hydroxytryptophan (5-HTP) derived from *Griffonia simplicifolia* seeds, along with B-group vitamins, specifically vitamin B6 (pyridoxine hydrochloride) and vitamin B1 (thiamine hydrochloride). Ceriptan is designed to support healthy brain and nervous system function, improve mood, reduce stress, and promote healthy sleep patterns. 5-HTP serves as a direct precursor to serotonin and melatonin, neurotransmitters that regulate mood, sleep, and appetite, while vitamins B1 and B6 play essential roles in energy metabolism and nervous system maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ceriptan.